The Claim
In non-diabetic adults with overweight or obesity, once-weekly administration of semaglutide at a dose of 2.4 mg over 68 weeks leads to greater improvements in participant-reported physical functioning and health-related quality of life, as measured by the SF-36 physical functioning and IWQOL-Lite-CT scales, compared to placebo.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a weekly semaglutide shot (2.4 mg) for about a year helps people with extra weight feel more physically capable and improves their overall quality of life—more than a dummy pill would.
See the scientific wording
Once-weekly semaglutide at 2.4 mg increases participant-reported physical functioning and health-related quality of life in non-diabetic adults with overweight or obesity over 68 weeks, with significantly greater improvements in SF-36 physical functioning and IWQOL-Lite-CT scores compared to placebo.
What the research says
1 studyStudy: Once-Weekly Semaglutide in Adults with Overweight or Obesity.
The study tested the same drug and dose mentioned in the claim and found that people felt physically better after using it for almost a year compared to those on a placebo.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.